ICD-10 Coding for Uterus Carcinoma(C54.1, C79.82)
Complete ICD-10-CM coding and documentation guide for Uterus Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Uterus Carcinoma
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C54.1 | Malignant neoplasm of endometrium | Use when the primary site of the carcinoma is confirmed to be the endometrium. |
|
| C79.82 | Secondary malignant neoplasm of genital organs | Use when documenting secondary malignancies in genital organs. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for uterus carcinoma
Essential facts and insights about Uterus Carcinoma
Primary ICD-10-CM Codes for uterus carcinoma
Decision Criteria
clinical Criteria
- Histological confirmation of endometrial carcinoma
coding Criteria
- Primary site confirmed as endometrium
Applicable To
- Endometrioid adenocarcinoma
Clinical Validation Requirements
- Histological confirmation of endometrial origin
- Biopsy showing endometrioid adenocarcinoma
Code-Specific Risks
- Confusion with other uterine codes like C54.2 or C53.9
Coding Notes
- Ensure histological confirmation of endometrial origin before using C54.1.
C79.82 - Secondary malignant neoplasm of genital organs
Use when documenting secondary malignancies in genital organs.
Applicable To
- Metastasis to genital organs
Clinical Validation Requirements
- Imaging or pathology confirming metastasis from another primary site
Coding Notes
Ensure primary site is coded before using C79.82.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Secondary malignant neoplasm of genital organs
C79.82Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Uterus Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C54.1.
Impact
Clinical: Inaccurate diagnosis leading to inappropriate treatment., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation Strategy
Ensure detailed histological reports are included in patient records.
Impact
Reimbursement: Incorrect DRG assignment leading to reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation Strategy
Verify the primary site of the tumor through histological reports.
Impact
Lack of detailed histological documentation can lead to audit issues.
Mitigation Strategy
Ensure all histological findings are thoroughly documented.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Uterus Carcinoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Uterus Carcinoma
Use these documentation templates to ensure complete and accurate documentation for Uterus Carcinoma. These templates include all required elements for proper coding and billing.
Endometrial carcinoma diagnosis
Specialty: OncologyRequired Elements
- Histological type
- Tumor size
- Invasion depth
- Staging
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Uterus Carcinoma? Ask your questions below.